Frédéric Triebel
Chief Tech/Sci/R&D Officer chez IMMUTEP LIMITED
Fortune : 2 M $ au 31/03/2024
Profil
Frédéric Triebel is the founder.
He founded Immutep SAS in 2001 and holds the title of Co-Chief Executive Officer.
Currently, Dr. Triebel is the Executive Director & Chief Scientific Officer at Immutep Ltd.
since 2014.
Dr. Triebel's former positions include Director at Institut National de la Santé & de la Recherche Médicale from 1991 to 1996, Professor at Université de Paris IV Paris-Sorbonne, and Principal at IGREC SASU.
Dr. Triebel obtained a doctorate degree from Université Paris 1 Panthéon-Sorbonne.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMMUTEP LTD
0,73% | 22/08/2023 | 8 653 764 ( 0,73% ) | 2 M $ | 31/03/2024 |
Postes actifs de Frédéric Triebel
| Sociétés | Poste | Début |
|---|---|---|
| IMMUTEP LIMITED | Chief Tech/Sci/R&D Officer | 12/12/2014 |
Immutep SAS
 Immutep SAS Pharmaceuticals: MajorHealth Technology Immutep SAS specializes in biotechnology research and development. It develops immunotherapy treatments for cancer and autoimmune diseases. The company was founded by Frédéric Triebel on October 17, 2001 and is headquartered Orsay, France. | Chief Executive Officer | 14/07/2016 |
Anciens postes connus de Frédéric Triebel
| Sociétés | Poste | Fin |
|---|---|---|
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Director/Board Member | 01/01/1996 |
| Université de Paris IV Paris-Sorbonne | Corporate Officer/Principal | - |
IGREC SASU
 IGREC SASU Miscellaneous Commercial ServicesCommercial Services IGREC SASU provides accounting services. It offers concepts of recovery before maturity, detection, classification and handling of disputes, and the concepts of sustainable improvement of payment delays and customer satisfaction. The company was founded in 1993 and is headquartered in Caraman, France. | Corporate Officer/Principal | - |
Formation de Frédéric Triebel
| Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IMMUTEP LIMITED | Health Technology |
| Entreprise privées | 4 |
|---|---|
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Commercial Services |
| Université de Paris IV Paris-Sorbonne | Consumer Services |
IGREC SASU
IGREC SASU Miscellaneous Commercial ServicesCommercial Services IGREC SASU provides accounting services. It offers concepts of recovery before maturity, detection, classification and handling of disputes, and the concepts of sustainable improvement of payment delays and customer satisfaction. The company was founded in 1993 and is headquartered in Caraman, France. | Commercial Services |
Immutep SAS
Immutep SAS Pharmaceuticals: MajorHealth Technology Immutep SAS specializes in biotechnology research and development. It develops immunotherapy treatments for cancer and autoimmune diseases. The company was founded by Frédéric Triebel on October 17, 2001 and is headquartered Orsay, France. | Health Technology |
